Mechanism-based antioxidant therapies promise to prevent diabetic complications?

Journal of Diabetes Investigation

Volumn 4, Issue 2, 2013, Pages 105-107

  Nishikawa, Takeshi ^a   Araki, Eiichi ^b  

^a Departments of Molecular Diabetology   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BARDOXOLONE METHYL; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IDEBENONE; METFORMIN; MITOQUINONE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PLACEBO; POLYOL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCHIFF BASE; SULFORAPHANE; TAURINE; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; UBIQUINONE; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL EFFECTIVENESS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG EFFICACY; EDITORIAL; ELECTRON TRANSPORT; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

EID: 84878366185     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12041     Document Type: Editorial

References (6)

1. Araki E, Nishikawa T. Oxidative stress: a cause and therapeutic target of diabetic complications. J Diabetes Invest 2010; 1: 90-96.
2. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-790.
3. Gane EJ, Weilert F, Orr DW, et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 2011; 30: 1019-1026.
4. Kukidome D, Nishikawa T, Sonoda K, et al. Activation of AMP-Activated Protein Kinase Reduces Hyperglycemia-Induced Mitochondrial Reactive Oxygen Species Production and Promotes Mitochondrial Biogenesis in Human Umbilical Vein Endothelial Cells. Diabetes 2006; 55: 120-127.
5. Lee IK. Adenosine monophosphate kinase activator α-lipoic acid: a promising therapeutic agent for metabolic syndrome? J Diabetes Invest 2011; 2: 241-242.
6. Pergola PE, Raskin P, Toto RD, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 2011; 365: 327-336.